Cyclin D3/CDK11^p58 Complex Is Involved in the Repression of Androgen Receptor

REFERENCES

• Alen, P., F. Claessens, G. Verhoeven, W. Rombauts, and B. Peeters. 1999. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol. Cell. Biol. 19:6085–6097.
   PubMed Web of Science ®Google Scholar
• Bartkova, J., J. Lukas, M. Strauss, and J. Bartek. 1998. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 17:1027–1037.
   PubMedGoogle Scholar
• Belandia, B., S. M. Powell, J. M. Garcia-Pedrero, M. M. Walker, C. L. Bevan, and M. G. Parker. 2005. Hey1, a mediator of Notch signaling, is an androgen receptor corepressor. Mol. Cell. Biol. 25:1425–1436.
   PubMedGoogle Scholar
• Blok, L. J., P. E. de Ruiter, and A. O. Brinkmann. 1996. Androgen receptor phosphorylation. Endocr. Res. 22:197–219.
   PubMed Web of Science ®Google Scholar
• Bodwell, J. E., E. Orti, J. M. Coull, D. J. Pappin, L. I. Smith, and F. Swift. 1991. Identification of phosphorylated sites in the mouse glucocorticoid receptor. J. Biol. Chem. 266:7549–7555.
   PubMed Web of Science ®Google Scholar
• Bodwell, J. E., J. C. Webster, C. M. Jewell, J. A. Cidlowski, J. M. Hu, and A. Munck. 1998. Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J. Steroid Biochem. Mol. Biol. 65:91–99.
   PubMed Web of Science ®Google Scholar
• Bunnell, B. A., L. S. Heath, D. E. Adams, J. M. Lahti, and V. J. Kidd. 1990. Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle. Proc. Natl. Acad. Sci. USA 87:7467–7471.
   PubMed Web of Science ®Google Scholar
• Burd, C. J., C. E. Petre, H. Moghadam, E. M. Wilson, and K. E. Knudsen. 2005. Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression. Mol. Endocrinol. 19:607–620.
   PubMedGoogle Scholar
• Chang, C., A. Saltzman, S. Yeh, W. Young, E. Keller, H. J. Lee, C. Wang, and A. Mizokami. 1995. Androgen receptor: an overview. Crit. Rev. Eukaryot. Gene Expr. 5:97–125.
   PubMed Web of Science ®Google Scholar
• Chang, C. S., J. Kokontis, and S. T. Liao. 1988. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240:324–326.
   PubMed Web of Science ®Google Scholar
• Chen, S., Y. Xu, X. Yuan, G. J. Bubley, and S. P. Balk. 2006. Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1. Proc. Natl. Acad. Sci. USA 103:15969–15974.
   PubMed Web of Science ®Google Scholar
• Cornelis, S., Y. Bruynooghe, G. Denecker, S. Van Huffel, S. Tinton, and R. Beyaert. 2000. Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol. Cell 5:597–605.
   PubMed Web of Science ®Google Scholar
• Dave, B. J., D. L. Pickering, M. M. Hess, D. D. Weisenburger, J. O. Armitage, and W. G. Sanger. 1999. Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non-Hodgkin lymphoma. Cancer Genet. Cytogenet. 108:120–126.
   PubMedGoogle Scholar
• Dehm, S. M., and D. J. Tindall. 2006. Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells. J. Biol. Chem. 281:27882–27893.
   PubMed Web of Science ®Google Scholar
• Dehm, S. M., and D. J. Tindall. 2005. Regulation of androgen receptor signaling in prostate cancer. Expert Rev. Anticancer Ther. 5:63–74.
   PubMed Web of Science ®Google Scholar
• de Launoit, Y., R. Veilleux, M. Dufour, J. Simard, and F. Labrie. 1991. Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells. Cancer Res. 51:5165–5170.
   PubMedGoogle Scholar
• Gioeli, D., B. E. Black, V. Gordon, A. Spencer, C. T. Kesler, S. T. Eblen, B. M. Paschal, and M. J. Weber. 2006. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol. Endocrinol. 20:503–515.
   PubMed Web of Science ®Google Scholar
• Gioeli, D., S. B. Ficarro, J. J. Kwiek, D. Aaronson, M. Hancock, A. D. Catling, F. M. White, R. E. Christian, R. E. Settlage, J. Shabanowitz, D. F. Hunt, and M. J. Weber. 2002. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J. Biol. Chem. 277:29304–29314.
   PubMed Web of Science ®Google Scholar
• Heinlein, C. A., and C. Chang. 2004. Androgen receptor in prostate cancer. Endocr. Rev. 25:276–308.
   PubMed Web of Science ®Google Scholar
• Horoszewicz, J. S., S. S. Leong, E. Kawinski, J. P. Karr, H. Rosenthal, T. M. Chu, E. A. Mirand, and G. P. Murphy. 1983. LNCaP model of human prostatic carcinoma. Cancer Res. 43:1809–1818.
   PubMed Web of Science ®Google Scholar
• Hu, D., A. Mayeda, J. H. Trembley, J. M. Lahti, and V. J. Kidd. 2003. CDK11 complexes promote pre-mRNA splicing. J. Biol. Chem. 278:8623–8629.
   PubMed Web of Science ®Google Scholar
• Jemal, A., R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, and M. J. Thun. 2006. Cancer statistics, 2006. CA Cancer J. Clin. 56:106–130.
   PubMed Web of Science ®Google Scholar
• Jenster, G., H. A. van der Korput, C. van Vroonhoven, T. H. van der Kwast, J. Trapman, and A. O. Brinkmann. 1991. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol. Endocrinol. 5:1396–1404.
   PubMed Web of Science ®Google Scholar
• Knotts, T. A., R. S. Orkiszewski, R. G. Cook, D. P. Edwards, and N. L. Weigel. 2001. Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites. J. Biol. Chem. 276:8475–8483.
   PubMed Web of Science ®Google Scholar
• Knudsen, K. E., K. C. Arden, and W. K. Cavenee. 1998. Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells. J. Biol. Chem. 273:20213–20222.
   PubMed Web of Science ®Google Scholar
• Knudsen, K. E., W. K. Cavenee, and K. C. Arden. 1999. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res. 59:2297–2301.
   PubMedGoogle Scholar
• Lahti, J. M., M. Valentine, J. Xiang, B. Jones, J. Amann, J. Grenet, G. Richmond, A. T. Look, and V. J. Kidd. 1994. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nat. Genet. 7:370–375.
   PubMedGoogle Scholar
• Lahti, J. M., J. Xiang, L. S. Heath, D. Campana, and V. J. Kidd. 1995. PITSLRE protein kinase activity is associated with apoptosis. Mol. Cell. Biol. 15:1–11.
   PubMed Web of Science ®Google Scholar
• Lim, J. T., M. Mansukhani, and I. B. Weinstein. 2005. Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells. Proc. Natl. Acad. Sci. USA 102:5156–5161.
   PubMed Web of Science ®Google Scholar
• Lin, H. K., S. Yeh, H. Y. Kang, and C. Chang. 2001. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc. Natl. Acad. Sci. USA 98:7200–7205.
   PubMed Web of Science ®Google Scholar
• MacLean, H. E., G. L. Warne, and J. D. Zajac. 1997. Localization of functional domains in the androgen receptor. J. Steroid Biochem. Mol. Biol. 62:233–242.
   PubMed Web of Science ®Google Scholar
• Metzger, E., M. Wissmann, N. Yin, J. M. Muller, R. Schneider, A. H. Peters, T. Gunther, R. Buettner, and R. Schule. 2005. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437:436–439.
   PubMed Web of Science ®Google Scholar
• Moilanen, A. M., U. Karvonen, H. Poukka, O. A. Janne, and J. J. Palvimo. 1998. Activation of androgen receptor function by a novel nuclear protein kinase. Mol. Biol. Cell 9:2527–2543.
   PubMed Web of Science ®Google Scholar
• Narayanan, R., A. A. Adigun, D. P. Edwards, and N. L. Weigel. 2005. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Mol. Cell. Biol. 25:264–277.
   PubMed Web of Science ®Google Scholar
• Nelson, M. A., M. E. Ariza, J. M. Yang, F. H. Thompson, R. Taetle, J. M. Trent, J. Wymer, K. Massey-Brown, M. Broome-Powell, J. Easton, J. M. Lahti, and V. J. Kidd. 1999. Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma. Cancer Genet. Cytogenet. 108:91–99.
   PubMedGoogle Scholar
• Perlman, E. J., M. B. Valentine, C. A. Griffin, and A. T. Look. 1996. Deletion of 1p36 in childhood endodermal sinus tumors by two-color fluorescence in situ hybridization: a pediatric oncology group study. Genes Chromosomes Cancer 16:15–20.
   PubMedGoogle Scholar
• Petre, C. E., Y. B. Wetherill, M. Danielsen, and K. E. Knudsen. 2002. Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity. J. Biol. Chem. 277:2207–2215.
   PubMedGoogle Scholar
• Petretti, C., M. Savoian, E. Montembault, D. M. Glover, C. Prigent, and R. Giet. 2006. The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. EMBO Rep. 7:418–424.
   PubMed Web of Science ®Google Scholar
• Poetsch, M., T. Dittberner, and C. Woenckhaus. 2001. Does the PITSLRE gene complex contribute to the pathogenesis of malignant melanoma of the skin? A study of patient-derived tumor samples. Cancer Genet. Cytogenet. 128:181–182.
   PubMedGoogle Scholar
• Quayle, S. N., and M. D. Sadar. 2007. 14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens. Cancer Lett. 254:137–145.
   PubMedGoogle Scholar
• Reid, J., R. Betney, K. Watt, and I. J. McEwan. 2003. The androgen receptor transactivation domain: the interplay between protein conformation and protein-protein interactions. Biochem. Soc. Trans. 31:1042–1046.
   PubMedGoogle Scholar
• Reutens, A. T., M. Fu, C. Wang, C. Albanese, M. J. McPhaul, Z. Sun, S. P. Balk, O. A. Janne, J. J. Palvimo, and R. G. Pestell. 2001. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol. Endocrinol. 15:797–811.
   PubMed Web of Science ®Google Scholar
• Rogatsky, I., J. M. Trowbridge, and M. J. Garabedian. 1999. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex. J. Biol. Chem. 274:22296–22302.
   PubMed Web of Science ®Google Scholar
• Sachs, A. B. 2000. Cell cycle-dependent translation initiation: IRES elements prevail. Cell 101:243–245.
   PubMedGoogle Scholar
• Salas, T. R., J. Kim, F. Vakar-Lopez, A. L. Sabichi, P. Troncoso, G. Jenster, A. Kikuchi, S. Y. Chen, L. Shemshedini, M. Suraokar, C. J. Logothetis, J. DiGiovanni, S. M. Lippman, and D. G. Menter. 2004. Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity. J. Biol. Chem. 279:19191–19200.
   PubMedGoogle Scholar
• Sharma, M., M. Zarnegar, X. Li, B. Lim, and Z. Sun. 2000. Androgen receptor interacts with a novel MYST protein, HBO1. J. Biol. Chem. 275:35200–35208.
   PubMedGoogle Scholar
• Shen, X., Y. Yang, W. Liu, M. Sun, J. Jiang, H. Zong, and J. Gu. 2004. Identification of the p28 subunit of eukaryotic initiation factor 3(eIF3k) as a new interaction partner of cyclin D3. FEBS Lett. 573:139–146.
   PubMed Web of Science ®Google Scholar
• Slagsvold, T., I. Kraus, T. Bentzen, J. Palvimo, and F. Saatcioglu. 2000. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors. Mol. Endocrinol. 14:1603–1617.
   PubMedGoogle Scholar
• Trembley, J. H., D. Hu, L. C. Hsu, C. Y. Yeung, C. Slaughter, J. M. Lahti, and V. J. Kidd. 2002. PITSLRE p110 protein kinases associate with transcription complexes and affect their activity. J. Biol. Chem. 277:2589–2596.
   PubMedGoogle Scholar
• Wang, L., C. L. Hsu, and C. Chang. 2005. Androgen receptor corepressors: an overview. Prostate 63:117–130.
   PubMed Web of Science ®Google Scholar
• Weigel, N. L. 1996. Steroid hormone receptors and their regulation by phosphorylation. Biochem. J. 319:657–667.
   PubMed Web of Science ®Google Scholar
• Wu, W., B. M. Slomovitz, P. T. Soliman, K. M. Schmeler, J. Celestino, M. R. Milam, and K. H. Lu. 2006. Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma. Int. J. Gynecol. Cancer 16:1668–1672.
   PubMedGoogle Scholar
• Xiang, J., J. M. Lahti, J. Grenet, J. Easton, and V. J. Kidd. 1994. Molecular cloning and expression of alternatively spliced PITSLRE protein kinase isoforms. J. Biol. Chem. 269:15786–15794.
   PubMedGoogle Scholar
• Yamamoto, A., Y. Hashimoto, K. Kohri, E. Ogata, S. Kato, K. Ikeda, and M. Nakanishi. 2000. Cyclin E as a coactivator of the androgen receptor. J. Cell Biol. 150:873–880.
   PubMed Web of Science ®Google Scholar
• Yang, Q., K. M. Fung, W. V. Day, B. P. Kropp, and H. K. Lin. 2005. Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival. Cancer Cell Int. 5:8.
   PubMed Web of Science ®Google Scholar
• Ye, J. Z., and T. de Lange. 2004. TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex. Nat. Genet. 36:618–623.
   PubMed Web of Science ®Google Scholar
• Yeh, S., H. K. Lin, H. Y. Kang, T. H. Thin, M. F. Lin, and C. Chang. 1999. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc. Natl. Acad. Sci. USA 96:5458–5463.
   PubMed Web of Science ®Google Scholar
• Zhang, S., M. Cai, S. Zhang, S. Xu, S. Chen, X. Chen, C. Chen, and J. Gu. 2002. Interaction of p58(PITSLRE), a G2/M-specific protein kinase, with cyclin D3. J. Biol. Chem. 277:35314–35322.
   PubMedGoogle Scholar
• Zhang, Y., C. A. Beck, A. Poletti, J. P. Clement IV, P. Prendergast, T.-T. Yip, T. W. Hutchens, D. P. Edwards, and N. L. Weigel. 1997. Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol. Endocrinol. 11:823–832.
   PubMedGoogle Scholar
• Zhou, Z. X., J. A. Kemppainen, and E. M. Wilson. 1995. Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol. Endocrinol. 9:605–615.
   PubMedGoogle Scholar
• Zhu, Z., R. R. Becklin, D. M. Desiderio, and J. T. Dalton. 2001. Identification of a novel phosphorylation site in human androgen receptor by mass spectrometry. Biochem. Biophys. Res. Commun. 284:836–844.
   PubMedGoogle Scholar
• Zong, H., Z. Li, L. Liu, Y. Hong, X. Yun, J. Jiang, Y. Chi, H. Wang, X. Shen, Y. Hu, Z. Niu, and J. Gu. 2005. Cyclin-dependent kinase 11(p58) interacts with HBO1 and enhances its histone acetyltransferase activity. FEBS Lett. 579:3579–3588.
   PubMedGoogle Scholar